Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-29
2005-03-29
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S004100
Reexamination Certificate
active
06872709
ABSTRACT:
The present invention provides a therapeutic agent and therapeutic method for treatment of mastitis in livestock comprising glycyrrhizin and pharmaceutically acceptable salts thereof as effective ingredients.
REFERENCES:
patent: 4678772 (1987-07-01), Segal et al.
patent: 798655 (1957-03-01), None
patent: 799415 (1957-03-01), None
patent: 843135 (1958-06-01), None
patent: 172332 (1989-07-01), None
patent: 06-305932 (1994-11-01), None
Nagai et al., Japan J. Pharmacol. 1992, 58, 209-218.*
Fujisawa, Yumiko, et al., “Glycyrrhizin Inhibits the Lytic Pathway of Complement-Possible Mechanism of Its Anti-Inflammatory Effect on Liver Cells in Viral Hepatitis,”Microbiol. Immunol., vol. 44, No. 9, pp. 799-804 (2000).
Fukai, Toshio, et al., “Cytotoxic Activity of Low Molecular Weight Polyphenols against Human Oral Tumor Cell Lines,”Anticancer Research, vol. 20, pp. 2525-2536 (2000).
Jeong, H., et al., Induction of Inducible Nitric Oxide Synthase Expression by 18β-glycyrrhetinic Acid in Macrophages,FEBS Letters, vol. 513., pp. 208-212 (2002).
Kai, Kenzo, et al., Anti-inflammatory effects of Intrammamary Infusions of Glycyrrhizin in Lactating Cows with Mastitis Caused by Coagulase-negative Staphylococci,AJVR, vol. 64, No. 10, pp. 1213-1220 (2003).
Mishima, Mathiro et al., “Studies on glycyrrhetinate and its derivatives as nasal absorption promoter of insulin,”Drug Delivery System, p. 88, 1989, issue 4.
Okada, Kenzo, et al., Identification of Antimicrobial and Antioxidant Constituents from Licorice of Rusian and Xhijiang Origin,Chem. Pharm. Bull., vol. 37, No. 9, pp. 2528-2530 (1989).
Sakagami, H., et al., “Induction of Apoptosis by Flavones, Flavonols (3-Hydroxyflavones) and Isoprenoid-Substituted Flavonoids in Human Oral Tumor Cell Lines”,Anticancer Research, vol. 20, pp. 271-278 (2000).
Suzuki, H., et al., “Effects of Glycyrrhizin on Biochemical Tests in Patients with Chronic Hepatitis,”Asian Med. J., vol. 26, No. 7, pp. 423-438.
Utsunomiya, Tokuichiro et al., “Glycyrrhizin (20 β-carboxy-11-oxo-30-norolean-12-en-3β-yl-2-O-β-D-glucopyranuronosyl-α-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1,”Immunology Letters, vol. 44, pp. 59-66 (1995).
Kai Kenzo
Komine Ken-ichi
Kumagai Katsuo
Kilpatrick & Stockton LLP
Krishnan Ganapathy
Kyoritsu Seiyaku Corporation
Wilson James O.
LandOfFree
Therapeutic agent for mastitis of livestock and method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for mastitis of livestock and method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for mastitis of livestock and method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3444379